Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.41% | 6.95% | -0.17% | 9.65% | 22.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.41% | 6.95% | -0.17% | 9.65% | 22.77% |
| Cost of Revenue | -2.99% | -8.66% | -15.55% | 2.48% | 27.03% |
| Gross Profit | 19.13% | 13.91% | 6.84% | 12.79% | 21.00% |
| SG&A Expenses | -38.94% | -23.01% | -5.50% | 16.13% | 44.83% |
| Depreciation & Amortization | 12.56% | 10.14% | 6.25% | 0.02% | -5.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.54% | -18.30% | -6.81% | 12.25% | 37.33% |
| Operating Income | 93.16% | 60.49% | 19.23% | -17.33% | -67.44% |
| Income Before Tax | 17.37% | -65.41% | -325.39% | -402.88% | -591.45% |
| Income Tax Expenses | 313.54% | 372.53% | 516.60% | 230.83% | -581.44% |
| Earnings from Continuing Operations | -53.73% | -180.20% | -608.03% | -597.02% | -593.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.73% | -180.20% | -608.03% | -597.02% | -593.82% |
| EBIT | 93.16% | 60.49% | 19.23% | -17.33% | -67.44% |
| EBITDA | 101.18% | 64.89% | 17.03% | -24.41% | -82.66% |
| EPS Basic | -54.17% | -182.01% | -623.90% | -531.68% | -405.14% |
| Normalized Basic EPS | 85.74% | 55.76% | 19.98% | -8.67% | -44.54% |
| EPS Diluted | -54.07% | -179.67% | -599.55% | -506.61% | -382.35% |
| Normalized Diluted EPS | 85.74% | 55.18% | 17.54% | -12.28% | -49.87% |
| Average Basic Shares Outstanding | 12.22% | 7.38% | 2.41% | 7.16% | 12.38% |
| Average Diluted Shares Outstanding | 15.24% | 6.91% | -1.31% | 3.09% | 7.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |